Evidence map›Paper›PMID 38770222›Full record

ArticleeNeurologicalSci2024

Corrected speciation and gyromitrin content of false morels linked to ALS patients with mostly slow-acetylator phenotypes.

Emmeline Lagrange, Marie-Anne Loriot, Nirmal K Chaudhary, Pam Schultz, Alden C Dirks, Claire Guissart, Timothy Y James, Jean Paul Vernoux, William Camu, Ashootosh Tripathi and 1 more

Abstract read
In one paragraph

Article in eNeurologicalSci, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Challenges of modelling TDP-43 pathology in mice.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emmeline LagrangeDepartment of Neurology, Reference Center of Neuromuscular Disease and ALS Consultations, Grenoble University Hospital, Grenoble, France.
Marie-Anne LoriotDepartment of Clinical Chemistry, European Georges-Pompidou hospital, Assistance Publique-Hôpitaux de Paris, University Paris Cité, INSERM UMR-S1138, Centre de Recherches des Cordeliers, 75908 Paris Cedex 15, France.
Nirmal K ChaudharyNatural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Pam SchultzNatural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Alden C DirksDepartment of Ecology and Evolution, University of Michigan, Ann Arbor, MI 48109, USA.
Claire GuissartLaboratoire de Biochimie et Biologie Moleculaire, CHU Nimes, Nimes, Motoneuron Disease: Pathophysiology and Therapy, INM, Univ. Montpellier, Montpellier, France.
Timothy Y JamesDepartment of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA.
Jean Paul VernouxUnité de Recherche Aliments Bioprocédés Toxicologie Environnements (ABTE) EA 4651, Normandie University, UNICAEN, 14000 Caen, France.
William CamuNM, Université Montpellier, INSERM, CNRS, Montpellier, France.
Ashootosh TripathiNatural Products Discovery Core, Life Sciences Institute, University of Michigan, 48109, USA.
Peter S SpencerOregon Health & Science University, Portland, OR 97239, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A case-control study of sporadic amyotrophic lateral sclerosis (ALS) in a mountainous village in the French Alps discovered an association of cases with a history of eating wild fungi (false morels) collected locally and initially identified and erroneously reported as

Indexed as

Amyotrophic lateral sclerosisFalse morelsGenotoxicityGyromitrinNAT2 genotype

Identifiers

PMID38770222
PMCPMC11103407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.